Protease-mediated entry via the endosome of human coronavirus 229E

Journal of Virology

Volumn 83, Issue 2, 2009, Pages 712-721

  Kawase, Miyuki ^a   Shirato, Kazuya ^a   Matsuyama, Shutoku ^a   Taguchi, Fumihiro ^a  

^a NATIONAL INSTITUTE OF INFECTIOUS DISEASES   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE PROTEINASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; SMALL INTERFERING RNA; TRYPSIN; VITRONECTIN;

ARTICLE; CELL SURFACE; COMPARATIVE STUDY; CONTROLLED STUDY; CORONAVIRUS; ENDOSOME; HELA CELL; HEPATITIS VIRUS; HUMAN; HUMAN CELL; PH; PRIORITY JOURNAL; PROTEIN FUNCTION; SARS CORONAVIRUS; SYNCYTIUM; VIRION; VIRUS INFECTION;

CATHEPSINS; CORONAVIRUS 229E, HUMAN; CYSTEINE ENDOPEPTIDASES; ENDOSOMES; GENE KNOCKDOWN TECHNIQUES; HELA CELLS; HUMANS; HYDROGEN-ION CONCENTRATION; MEMBRANE GLYCOPROTEINS; MURINE HEPATITIS VIRUS; PEPTIDE HYDROLASES; PLAQUE ASSAY; RNA, SMALL INTERFERING; SARS VIRUS; VIRAL ENVELOPE PROTEINS; VIRUS INTERNALIZATION;

CORONAVIRUS; HUMAN CORONAVIRUS 229E; MURINE HEPATITIS VIRUS; SARS CORONAVIRUS;

EID: 58149526807     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.01933-08     Document Type: Article

References (52)

1. Ami, Y., N. Nagata, K. Shirato, R. Watanabe, N. Iwata, K. Nakagaki, S. Fukushi, M. Saijo, S. Morikawa, and F. Taguchi. 2008. Co-infection of respiratory bacterium with severe acute respiratory syndrome coronavirus induces an exacerbated pneumonia in mice. Microbiol. Immunol. 52:118-127.
2. Appleyard, G., and M. Tisdale. 1985. Inhibition of the growth of human coronavirus 229E by leupeptin. J. Gen. Virol. 66:363-366.
3. Bonavia, A., B. D. Zelus, D. E. Wentworth, P. J. Talbot, and K. V. Holmes. 2003. Identification of a receptor-binding domain of the spike glycoprotein of human coronavirus HCoV-229E. J. Virol. 77:2530-2538.
4. Bosch, B. J., W. Bartelink, and P. J. Rottier. 2008. Cathepsin L functionally cleaves the severe acute respiratory syndrome coronavirus class I fusion protein upstream of rather than adjacent to the fusion peptide. J. Virol. 82:8887-8890.
5. Bosch, B. J., B. E. Martina, R. Van Der Zee, J. Lepault, B. J. Haijema, C. Versluis, A. J. Heck, R. De Groot, A. D. Osterhaus, and P. J. Rottier. 2004. Severe acute respiratory syndrome coronavirus (SARS-CoV) infection inhibition using spike protein heptad repeat-derived peptides. Proc. Natl. Acad. Sci. USA 101:8455-8460.
6. Cavanagh, D. 1995. The coronavirus surface glycoprotein, p. 73-113. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, NY.
7. Chan, D. C., and P. S. Kim. 1998. HIV entry and its inhibition. Cell 93:681-684.
8. Chandran, K., N. J. Sullivan, U. Felbor, S. P. Whelan, and J. M. Cunningham. 2005. Endosomal proteolysis of the Ebola virus glycoprotein is necessary for infection. Science 308:1643-1645.
9. Chu, V. C., L. J. McElroy, V. Chu, B. E. Bauman, and G. R. Whittaker. 2006. The avian coronavirus infectious bronchitis virus undergoes direct low-pH-dependent fusion activation during entry into host cells. J. Virol. 80:3180-3188.
10. Dveksler, G. S., M. N. Pensiero, C. B. Cardellichio, R. K. Williams, G. S. Jiang, K. V. Holmes, and C. W. Dieffenbach. 1991. Cloning of the mouse hepatitis virus (MHV) receptor: expression in human and hamster cell lines confers susceptibility to MHV. J. Virol. 65:6881-6891.
11. Dveksler, G. S., M. N. Pensiero, C. W. Dieffenbach, C. B. Cardellichio, A. A. Basile, P. E. Elia, and K. V. Holmes. 1993. Mouse hepatitis virus strain A59 and blocking antireceptor monoclonal antibody bind to the N-terminal domain of cellular receptor. Proc. Natl. Acad. Sci. USA 90:1716-1720.
12. Eckert, D. M., and P. S. Kim. 2001. Mechanisms of viral membrane fusion and its inhibition. Annu. Rev. Biochem. 70:777-810.
13. Eifart, P., K. Ludwig, C. Bottcher, C. A. de Haan, P. J. Rottier, T. Korte, and A. Herrmann. 2007. Role of endocytosis and low pH in murine hepatitis virus strain A59 cell entry. J. Virol. 81:10758-10768.
14. Follis, K. E., J. York, and J. H. Nunberg. 2006. Furin cleavage of the SARS coronavirus spike glycoprotein enhances cell-cell fusion but does not affect virion entry. Virology 350:358-369.
15. Fukushi, S., T. Mizutani, M. Saijo, S. Matsuyama, N. Miyajima, F. Taguchi, S. Itamura, I. Kurane, and S. Morikawa. 2005. Vesicular stomatitis virus pseudotyped with severe acute respiratory syndrome coronavirus spike protein. J. Gen. Virol. 86:2269-2274.
16. Gallagher, T. M., C. Escarmis, and M. J. Buchmeier. 1991. Alteration of the pH dependence of coronavirus-induced cell fusion: effect of mutations in the spike glycoprotein. J. Virol. 65:1916-1928.
17. Holmes, K. V., and S. R. Compton. 1995. Coronavirus receptors, p. 55-71. In S. G. Siddell (ed.), The Coronaviridae. Plenum Press, New York, NY.
18. Huang, I. C., B. J. Bosch, F. Li, W. Li, K. H. Lee, S. Ghiran, N. Vasilieva, T. S. Dermody, S. C. Harrison, P. R. Dormitzer, M. Farzan, P. J. Rottier, and H. Choe. 2006. SARS coronavirus, but not human coronavirus NL63, utilizes cathepsin L to infect ACE2-expressing cells. J. Biol. Chem. 281:3198-3203.
19. Kubo, H., S. Takase-Yoden, and F. Taguchi. 1993. Neutralization and fusion inhibition activities of monoclonal antibodies specific for the S1 subunit of the spike protein of neurovirulent murine coronavirus JHMV c1-2 variant. J. Gen. Virol. 74:1421-1425.
20. Kusanagi, K., H. Kuwahara, T. Katoh, T. Nunoya, Y. Ishikawa, T. Samejima, and M. Tajima. 1992. Isolation and serial propagation of porcine epidemic diarrhea virus in cell cultures and partial characterization of the isolate. J. Vet. Med. Sci. 54:313-318.
21. Lai, M. M., and D. Cavanagh. 1997. The molecular biology of coronaviruses. Adv. Virus Res. 48:1-100.
22. Li, F., M. Berardi, W. Li, M. Farzan, P. R. Dormitzer, and S. C. Harrison. 2006. Conformational states of the severe acute respiratory syndrome coronavirus spike protein ectodomain. J. Virol. 80:6794-6800.J.
23. Li, W., M. J. Moore, N. Vasilieva, J. Sui, S. K. Wong, M. A. Berne, M. Somasundaran, J. L. Sullivan, K. Luzuriaga, T. C. Greenough, H. Choe, and M. Farzan. 2003. Angiotensin-converting enzyme 2 is a functional receptor for the SARS coronavirus. Nature 426:450-454.
24. Matsuyama, S., and F. Taguchi. 2000. Impaired entry of soluble receptor-resistant mutants of mouse hepatitis virus into cells expressing MHVR2 receptor. Virology 273:80-89.
25. Matsuyama, S., and F. Taguchi. 2002. Receptor-induced conformational changes of murine coronavirus spike protein. J. Virol. 76:11819-11826.
26. Matsuyama, S., M. Ujike, S. Morikawa, M. Tashiro, and F. Taguchi. 2005. Protease-mediated enhancement of severe acute respiratory syndrome coronavirus infection. Proc. Natl. Acad. Sci. USA 102:12543-12547.
27. Miura, H. S., K. Nakagaki, and F. Taguchi. 2004. N-terminal domain of the murine coronavirus receptor CEACAM1 is responsible for fusogenic activation and conformational changes of the spike protein. J. Virol. 78:216-223.
28. Nomura, R., A. Kiyota, E. Suzaki, K. Kataoka, Y. Ohe, K. Miyamoto, T. Senda, and T. Fujimoto. 2004. Human coronavirus 229E binds to CD13 in rafts and enters the cell through caveolae. J. Virol. 78:8701-8708.
29. Pu, Y., and X. Zhang. 2008. Mouse hepatitis virus type 2 enters cells through a clathrin-mediated endocytic pathway independent of Eps15. J. Virol. 82:8112-8123.
30. Qiu, Z., S. T. Hingley, G. Simmons, C. Yu, J. Das Sarma, P. Bates, and S. R. Weiss. 2006. Endosomal proteolysis by cathepsins is necessary for murine coronavirus mouse hepatitis virus type 2 spike-mediated entry. J. Virol. 80:5768-5776.
31. Saeki, K., N. Ohtsuka, and F. Taguchi. 1997. Identification of spike protein residues of murine coronavirus responsible for receptor-binding activity by use of soluble receptor-resistant mutants. J. Virol. 71:9024-9031.
32. Sieczkarski, S. B., and G. R. Whittaker. 2005. Viral entry. Curr. Top. Microbiol. Immunol. 285:1-23.
33. Simmons, G., D. N. Gosalia, A. J. Rennekamp, J. D. Reeves, S. L. Diamond, and P. Bates. 2005. Inhibitors of cathepsin L prevent severe acute respiratory syndrome coronavirus entry. Proc. Natl. Acad. Sci. USA 102:11876-11881.
34. Simmons, G., J. D. Reeves, A. J. Rennekamp, S. M. Amberg, A. J. Piefer, and P. Bates. 2004. Characterization of severe acute respiratory syndrome-associated coronavirus (SARS-CoV) spike glycoprotein-mediated viral entry. Proc. Natl. Acad. Sci. USA 101:4240-4245.
35. Sturman, L. S., C. S. Ricard, and K. V. Holmes. 1985. Proteolytic cleavage of the E2 glycoprotein of murine coronavirus: activation of cell-fusing activity of virions by trypsin and separation of two different 90K cleavage fragments. J. Virol. 56:904-911.
36. Suzuki, H., and F. Taguchi. 1996. Analysis of the receptor-binding site of murine coronavirus spike protein. J. Virol. 70:2632-2636.
37. Taguchi, F., and S. Matsuyama. 2002. Soluble receptor potentiates receptor-independent infection by murine coronavirus. J. Virol. 76:950-958.
38. Taguchi, F., S. G. Siddell, H. Wege, and V. ter Meulen. 1985. Characterization of a variant virus selected in rat brains after infection by coronavirus mouse hepatitis virus JHM. J. Virol. 54:429-435.
39. Takada, A., C. Robison, H. Goto, A. Sanchez, K. G. Murti, M. A. Whitt, and Y. Kawaoka. 1997. A system for functional analysis of Ebola virus glycoprotein. Proc. Natl. Acad. Sci. USA 94:14764-14769.
40. Toth, T. E. 1982. Trypsin-enhanced replication of neonatal calf diarrhea coronavirus in bovine embryonic lung cells. Am. J. Vet. Res. 43:967-972.
41. Tusell, S. M., S. A. Schittone, and K. V. Holmes. 2007. Mutational analysis of aminopeptidase N, a receptor for several group 1 coronaviruses, identifies key determinants of viral host range. J. Virol. 81:1261-1273.
42. Ujike, M., H. Nishikawa, A. Otaka, N. Yamamoto, M. Matsuoka, E. Kodama, N. Fujii, and F. Taguchi. 2008. Heptad repeat-derived peptides block protease-mediated direct entry from the cell surface of severe acute respiratory syndrome coronavirus but not entry via the endosomal pathway. J. Virol. 82:588-592.
43. Watanabe, R., S. Matsuyama, K. Shirato, M. Maejima, S. Fukushi, S. Morikawa, and F. Taguchi. 2008. Entry from cell surface of SARS coronavirus with cleaved S protein as revealed by pseudotype virus bearing cleaved S protein. J. Virol. 82:11985-11991.
44. Wege, H., S. Siddell, and V. ter Meulen. 1982. The biology and pathogenesis of coronaviruses. Curr. Top. Microbiol. Immunol. 99:165-200.
45. White, J. M. 1990. Viral and cellular membrane fusion proteins. Annu. Rev. Physiol. 52:675-697.
46. Williams, R. K., G. S. Jiang, and K. V. Holmes. 1991. Receptor for mouse hepatitis virus is a member of the carcinoembryonic antigen family of glycoproteins. Proc. Natl. Acad. Sci. USA 88:5533-5536.
47. Wool-Lewis, R. J., and P. Bates. 1998. Characterization of Ebola virus entry by using pseudotyped viruses: identification of receptor-deficient cell lines. J. Virol. 72:3155-3160.
48. Yamada, Y. K., K. Takimoto, M. Yabe, and F. Taguchi. 1997. Acquired fusion activity of a murine coronavirus MHV-2 variant with mutations in the proteolytic cleavage site and the signal sequence of the S protein. Virology 227:215-219.
49. Yeager, C. L., R. A. Ashmun, R. K. Williams, C. B. Cardellichio, L. H. Shapiro, A. T. Look, and K. V. Holmes. 1992. Human aminopeptidase N is a receptor for human coronavirus 229E. Nature 357:420-422.
50. Yoshikura, H., and S. Tejima. 1981. Role of protease in mouse hepatitis virus-induced cell fusion. Studies with a cold-sensitive mutant isolated from a persistent infection. Virology 113:503-511.
51. Zamoto, A., F. Taguchi, S. Fukushi, S. Morikawa, and Y. K. Yamada. 2006. Identification of ferret ACE2 and its receptor function for SARS-coronavirus. Adv. Exp. Med. Biol. 581:519-522.
52. Zelus, B. D., J. H. Schickli, D. M. Blau, S. R. Weiss, and K. V. Holmes. 2003. Conformational changes in the spike glycoprotein of murine coronavirus are induced at 37°C either by soluble murine CEACAM1 receptors or by pH 8. J. Virol. 77:830-840.